Alnylam Pharmaceuticals (ALNY.MX) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-38.28
-15.35
7.59
30.52

Details

Expected EPS
-23.152364400000003
Actual EPS
30.5190258
Surprise EPS
53.67
Surprise Percent
+231.82%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of 30.5190258 per share for Q4 2023.

0 Comments

Share your thoughts